Hmdb loader

Search Results for metabolites

Searching metabolites for 108-19-0 returned 170749 results.
Displaying metabolites 170426 - 170450 of 170749 in total
Filter by metabolite status (default all):
Filter by biospecimen:
HMDB0008393
Thumb
Blood Feces Saliva Urine
PC(20:3(5Z,8Z,11Z)/P-18:1(9Z))
[2-({3-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0008425
Thumb
Blood Feces Saliva Urine
PC(20:3(8Z,11Z,14Z)/P-18:1(9Z))
[2-({3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0008491
Thumb
Blood Feces Saliva Urine
PC(20:4(8Z,11Z,14Z,17Z)/P-18:1(9Z))
[2-({3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0008524
Thumb
Blood Feces Saliva Urine
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(9Z))
[2-({3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0008588
Thumb
Blood Feces
PC(22:1(13Z)/P-18:1(11Z))
[2-({3-[(13Z)-docos-13-enoyloxy]-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0008721
Thumb
Blood Feces Urine
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))
[2-({3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011276
Thumb
Blood Feces Saliva Urine
PC(P-18:1(11Z)/18:1(9Z))
trimethyl(2-{[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato]oxy}ethyl)azanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011277
Thumb
Blood Feces Saliva Urine
PC(P-18:1(11Z)/18:2(9Z,12Z))
trimethyl(2-{[(2R)-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)azanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011278
Thumb
Blood Feces Saliva Urine
PC(P-18:1(11Z)/18:3(6Z,9Z,12Z))
trimethyl[2-({3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propyl phosphonato}oxy)ethyl]azanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011287
Thumb
Blood Feces Saliva Urine
PC(P-18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
(2-{[(2R)-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphono]oxy}ethyl)trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011288
Thumb
Blood Feces Saliva Urine
PC(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
(2-{[(2R)-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011292
Thumb
Blood
PC(P-18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
[2-({2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011297
Thumb
Blood Feces Saliva Urine
PC(P-18:1(11Z)/24:1(15Z))
trimethyl(2-{[(2R)-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-[(15Z)-tetracos-15-enoyloxy]propyl phosphonato]oxy}ethyl)azanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011317
Thumb
Blood Feces Saliva Urine
PC(P-18:1(9Z)/20:3(5Z,8Z,11Z))
(2-{[(2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011320
Thumb
Blood Feces Saliva Urine
PC(P-18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
(2-{[(2R)-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011325
Thumb
Blood
PC(P-18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
(2-{[(2R)-2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0011330
Thumb
Blood Feces Saliva Urine
PC(P-18:1(9Z)/24:1(15Z))
trimethyl(2-{[(2R)-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-2-[(15Z)-tetracos-15-enoyloxy]propyl phosphonato]oxy}ethyl)azanium
Matched description: … 18:0 and 18:1 (double bond in position 9) predominating. ... alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, …
HMDB0276026
Thumb
PI(16:0/20:3(5Z,8Z,14Z)-O(11S,12R))
[(2R)-3-(hexadecanoyloxy)-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(16:0/20:3(5Z,8Z,14Z)-O(11S,12R)) …
Matched description: … PI(16:0/20:3(5Z,8Z,14Z)-O(11S,12R)) is an oxidized phosphatidylinositol (PI). ... PI(16:0/20:3(5Z,8Z,14Z)-O(11S,12R)), in particular, consists of one chain of hexadecanoyl at the C-1 …
HMDB0276033
Thumb
PI(20:4(5Z,8Z,11Z,14Z)-OH(20)/16:0)
[(2R)-2-(hexadecanoyloxy)-3-{[(5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoyl]oxy}propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(20:4(5Z,8Z,11Z,14Z)-OH(20)/16:0) …
Matched description: … PI(20:4(5Z,8Z,11Z,14Z)-OH(20)/16:0) is an oxidized phosphatidylinositol (PI). ... PI(20:4(5Z,8Z,11Z,14Z)-OH(20)/16:0), in particular, consists of one chain of 20-Hydroxyeicosatetraenoyl …
HMDB0276049
Thumb
PI(20:4(5E,8Z,12Z,14Z)-OH(11R)/16:0)
[(2R)-2-(hexadecanoyloxy)-3-{[(5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]oxy}propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(20:4(5E,8Z,12Z,14Z)-OH(11R)/16:0) …
Matched description: … PI(20:4(5E,8Z,12Z,14Z)-OH(11R)/16:0) is an oxidized phosphatidylinositol (PI). ... PI(20:4(5E,8Z,12Z,14Z)-OH(11R)/16:0), in particular, consists of one chain of 11-Hydroxyeicosatetraenoyl …
HMDB0276068
Thumb
PI(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))
[(2R)-3-(hexadecanoyloxy)-2-{[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) …
Matched description: … PI(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidylinositol (PI). ... PI(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of hexadecanoyl at …
HMDB0276097
Thumb
PI(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/16:0)
[(2R)-3-{[(5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxy}-2-(hexadecanoyloxy)propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/16:0) …
Matched description: … PI(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/16:0) is an oxidized phosphatidylinositol (PI). ... PI(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/16:0), in particular, consists of one chain of Resolvin D5 …
HMDB0276099
Thumb
PI(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:0)
[(2R)-2-(hexadecanoyloxy)-3-{[(5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxy}propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:0) …
Matched description: … PI(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:0) is an oxidized phosphatidylinositol (PI). ... PI(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/16:0), in particular, consists of one chain of Lipoxin A5 at the …
HMDB0276104
Thumb
PI(16:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
[(2R)-3-(hexadecanoyloxy)-2-{[(5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl]oxy}propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(16:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) …
Matched description: … PI(16:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) is an oxidized phosphatidylinositol (PI). ... PI(16:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)), in particular, consists of one chain of hexadecanoyl at the …
HMDB0276110
Thumb
PI(16:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
[(2R)-3-(hexadecanoyloxy)-2-{[(4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoyl]oxy}propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched name: … PI(16:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) …
Matched description: … PI(16:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) is an oxidized phosphatidylinositol (PI). ... PI(16:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)), in particular, consists of one chain of hexadecanoyl at …